NCT06469333

Brief Summary

EMDR is a psychotherapeutic approach recommended by the World Health Organization (WHO) for the treatment of disorders such as post-traumatic stress disorder, anxiety, depression and, more generally, psychological distress. In all these disorders, intrusions are one of the symptoms leading to intense emotional distress. EMDR therapy, by making intrusions less emotional and less present in the mind (i.e. less vivid), would reduce psychological distress. This symptomatological reduction would be made possible by the therapist's application of alternating bilateral visual (rapid eye movements following a point from left to right), auditory (tones emitted alternately in the right ear and then in the left ear) and/or tactile (tapping with fingers on the left and right shoulders alternately) stimulations administered while the patient concentrates on his or her intrusive thoughts. Accordingly, the aim of this research is to investigate the efficacy of self-administration of Alternating Bilateral Stimulations (ABS), on the emotional intensity (emotionality) associated with negative intrusive thoughts (or intrusions).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Sep 2024Jun 2026

First Submitted

Initial submission to the registry

June 5, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 6, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

1.7 years

First QC Date

June 5, 2024

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurement of emotionality associated with an intrusive thought

    Emotionality will be assessed using the Subjective Units of Disturbance Scale (SUDS), which ranges from 0 ("no distress at all") to 10 ("maximum distress") and provides a subjective assessment of the disturbance associated with the intrusive thought.

    Before and after the experimental phase (7 days after Day 1), The first day after the experimental phase and one night's sleep (comprising 4 to 6 sleep cycles with an average duration of 90 minutes ), through study completion (21 days after D1)

Secondary Outcomes (4)

  • Assessment of the vividness of the intrusion

    Before and after the experimental phase (7 days after Day 1), The first day after the experimental phase and one night's sleep (comprising 4 to 6 sleep cycles with an average duration of 90 minutes ), through study completion (21 days after D1)

  • Psychological distress

    At day 1 (D1), before the experimental phase (7 days after Day 1), The first day after the experimental phase and one night's sleep (comprising 4 to 6 sleep cycles with an average duration of 90 minutes ), through study completion (21 days after D1)

  • Intrusion symptoms

    At day 1 (D1), the first day after the experimental phase and one night's sleep (comprising 4 to 6 sleep cycles with an average duration of 90 minutes ) , through study completion (21 days after D1).

  • Nature, impact and severity of insomnia

    the first day after the experimental phase and one night's sleep (comprising 4 to 6 sleep cycles with an average duration of 90 minutes )

Other Outcomes (3)

  • Heart rate variability (HRV)

    Before and during the experimental phase (7 days after Day 1)

  • Dissociative disorder

    At day 1 (D1)

  • Alcohol and drug consumption and the presence of psychotic disorders

    At day 1 (D1)

Study Arms (4)

Control Group

NO INTERVENTION

The participant is asked to concentrate on the image or, failing that, the sensory representation representing the worst aspect of the targeted intrusive thought for 10 seconds, and to stare at the black computer screen.

Eye movements (EM)

EXPERIMENTAL

The participant is asked to focus on the image or, failing that, the sensory representation representing the worst aspect of the targeted intrusive thought for 10 seconds and visually follow the horizontal displacement of a white dot (Ø 1cm) on the black screen at a constant speed of 1.2 Hz. This speed, implying the displacement of 1.2 left-right-left cycles per second, targets the saturation of working memory.

Behavioral: Eye movements (EM)

Eye movements and auditory stimulations (EM+AS)

EXPERIMENTAL

The participant will have to concentrate on the image or, failing that, the sensory representation representing the worst aspect of the targeted intrusive thought for 10 seconds and follow the horizontal displacement of a white dot on the computer screen, while simultaneously perceiving the auditory "beep" tones in the headphones provided. These tones will be at a rate of 1.2 Hz (i.e. 1.2 left ear-right ear-left ear alternations per second).

Behavioral: Eye movements (EM)Behavioral: Auditory stimulations

Eye movements, auditory stimulations and tactile stimulations (EM+AS+TS)

EXPERIMENTAL

The participant is asked to concentrate on the image or, failing that, the sensory representation representing the worst aspect of the targeted intrusive thought for 10 seconds, and to follow the horizontal displacement of a white dot on the computer screen and simultaneously perceive the "beeps", as well as the tactile self-stimulations applied at a constant speed of 1.2Hz (i.e. 1.2 left-right-left tapping cycles per second).

Behavioral: Eye movements (EM)Behavioral: Auditory stimulationsBehavioral: Tactile stimulations

Interventions

The participant focuses on the intrusive thought and visually follows the horizontal movement of a white dot (Ø 1 cm) on the black computer screen 8 times for 24 seconds.

Eye movements (EM)Eye movements and auditory stimulations (EM+AS)Eye movements, auditory stimulations and tactile stimulations (EM+AS+TS)

The participant focuses on the intrusive thoughts and hears the auditory "beeps" through the headphones provided 8 times for 24 seconds.

Eye movements and auditory stimulations (EM+AS)Eye movements, auditory stimulations and tactile stimulations (EM+AS+TS)

The participant focuses on the intrusive thought and applies tactile self-stimulation 8 times for 24 seconds.

Eye movements, auditory stimulations and tactile stimulations (EM+AS+TS)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Present symptoms of acute stress (score between 22 and 35 on the Impact Event Scale-Revised, IES-R) and/or PTSD (higher score or equal to 36 on the IES-R), but at least present moderate to high psychological distress (score equal to or greater than 8 on the Kessler Abbreviated Psychological Distress Scale, K6);
  • Being in need of psychotherapeutic follow-up but not having started it yet;
  • Be aged between 18 and 65 years inclusive;
  • Speak and write French (be able to understand information and complete questionnaires independently);
  • Have good vision (being able to follow the movement of a white point on a screen);
  • Have good hearing and tactile abilities (being able to perceive auditory and tactile tones);
  • Have a computer equipped with a webcam;
  • Be informed and sign informed consent.

You may not qualify if:

  • Be an adult protected under guardianship or curatorship;
  • Be a person subject to a judicial safeguard measure;
  • Present a lack of autonomy implying an impossibility in terms of administering questionnaires and filling out questionnaires;
  • Have a vision defect implying an impossibility of visual tracking of a white dot;
  • Present a hearing defect and/or tactile abilities implying an impossibility of perception;
  • Have a neurological condition constituting measurement biases (muscular dysfunctions, perceptual dysfunctions, etc.);
  • Suffer from psychotraumatic and dissociative disorders of complex type (respectively evaluated with regard to the anamestistic data of the patients and with a score greater than 25 on the dissociative experiences scale (Dissociative Experiences Scale, DES);
  • Do not present psychological distress (score less than 8 on the Kessler Abbreviated Psychological Distress Scale, K6) ;
  • Have a drug or alcohol dependence;
  • Benefit from ongoing psychotherapeutic monitoring;
  • Have already benefited from psychotherapeutic follow-up or have participated in studies in the last 6 months, both involving EMDR therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umr U1319 Inspiire

Vandœuvre-lès-Nancy, 54505, France

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Eye Movements

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

MovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaOcular Physiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Methodologist/Epidemiologist Head of Research Unit, Pierre Jane Centre

Study Record Dates

First Submitted

June 5, 2024

First Posted

June 21, 2024

Study Start

September 6, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

November 26, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations